Related Experiment Videos
Low-dosage prophylactic vancomycin in central-venous catheters for neonates
E Ocete1, A Ruíz-Extremera, A Goicoechea
1Department of Pediatrics, School of Medicine, University of Granada, Spain.
Early Human Development
|April 2, 1999
Summary
Prophylactic vancomycin via central venous catheters significantly reduced Gram-positive infections in neonatal intensive care units. This intervention proved effective even in high-risk neonates, offering a promising strategy against serious infections.
Area of Science:
- Neonatalogy
- Infectious Diseases
- Pharmacology
Background:
- Neonatal infections are a major cause of death and illness.
- Plasticized catheters, while beneficial for treatment, increase infection risk.
- Coagulase-negative staphylococci are common neonatal pathogens.
Purpose of the Study:
- To evaluate the efficacy of prophylactic vancomycin administration via central venous catheters in neonates.
- To assess the impact of this intervention on reducing Gram-positive infections in a neonatal intensive care unit.
Main Methods:
- A one-year study in a neonatal intensive care unit.
- Vancomycin was administered prophylactically through central venous catheters.
- Infection rates were compared between the intervention group and a control group.
Main Results:
- Prophylactic vancomycin significantly decreased Gram-positive infections.
- The intervention group had a higher prevalence of septic risk factors.
- The reduction in infections was observed despite increased risk factors.
Conclusions:
- Vancomycin prophylaxis via central venous catheters is effective in reducing Gram-positive infections in neonates.
- This strategy is beneficial even in neonates with multiple septic risk factors.
- The findings support the use of vancomycin for infection prevention in high-risk neonatal populations.